Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer.
Journal: Research square
Published: June 05, 2026
Loss of Flotillin-2 enhances trastuzumab emtansine internalization and cytotoxicity by relieving negative regulation of HER2 internalization in HER2-amplified cancers.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model.
Journal: Cancer letters
Published: March 13, 2026
Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.
Journal: Breast cancer research : BCR
Published: December 23, 2025
Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor Venetoclax.
Journal: Research square
Published: December 03, 2025
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclax.
Journal: Cell death & disease
Published: November 05, 2025
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 09, 2025
Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 09, 2025
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.
Journal: Nature communications
Published: September 26, 2025
Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health system.
Journal: Breast cancer research and treatment
Published: July 30, 2025
Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems.
Journal: Neuro-oncology
Published: July 08, 2025
Last Updated: 09/26/2026